5
Sept 18 (Reuters) – EMA: * EMA: CHMP CONCLUDED BENEFITS OF SODIUM OXYBATE SYRUP & ORAL SOLUTION CONTINUE TO OUTWEIGH RISKS FOR ALCOHOL WITHDRAWAL & ABSTINENCE * EMA: CHMP RECOMMENDED COMPANIES SHOULD
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)